Delivery Order SPE2DB22D2005-SPE2DB24FJSG1

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,714.54 for the supply of Abilify Maintena Extended-Release (ER) 400 mg syringes. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 24, 2024. The contract is a firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,346.48 firm fixed-price delivery order is for the supply of the pharmaceutical product Abilify Maintena ER 400 mg syringes, with a completion date of June 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,774.10, is for the provision of ABILIFY MAINTENA ER 400 MG SYRS, a specialty medication. The contract has an ultimate completion date of October 2, 2023 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $1,842.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Abilify Maintena ER 400 mg syringes, a medication used to treat certain mental health conditions. The contract is not a set-aside and represents an open competition. It has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,356.16 to provide ABILIFY MAINTENA ER 400 MG VLS medical products. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,927.45, is for the delivery of ABILIFY MAINTENA ER 400 MG SYRS, a specialty pharmaceutical product. The contract has a completion date of May 14, 2024 and is a firm fixed-price contract. The contract is not associated with a set-aside program and appears to be an open competition award....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Abilify Maintena ER 400 mg vials. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with an ultimate completion date of August 23, 2024 and a ceiling value of $2,471.47. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office Division, has been a long-standing supplier of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The award is for the supply of Abilify Maintena ER 400 mg vials, a specialty brand name medication, with a potential value of $5,016.99 and a completion date of February 2, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Abilify Maintena ER 400 mg vials. The contract has a firm fixed-price pricing type and a ceiling value of $5,853.96. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of medical commodities to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ABILIFY MAINTENA ER 400 MG SYRS, a pharmaceutical product, with a ceiling value of $20,006.39 and an ultimate completion date of April 4, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJSG1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award, valued at $3,346.48, is for the supply of Abilify Maintena ER 400 mg syringes, a specialty pharmaceutical product.

The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is valid through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide.

The contract does not have a set-aside designation and is scheduled for completion on September 6, 2024. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to deliver essential medical products to various government agencies and healthcare programs, including those operated by the Department of Defense and other federal entities.

Generated 12/5/24, 9:21 AM